Burning Rock Biotech (NASDAQ: BNR)
Burning Rock Biotech Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Burning Rock Biotech Company Info
Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The firm operates through the following segments: Central Laboratory Business, In-Hospital Business and Pharma Research and Development Services. Its products and clinical applications include companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction and tumor susceptibility tests. The company was founded by Yu Sheng Han in January 2014 and is headquartered in Guangzhou, China.
News & Analysis
No articles found.
Valuation
Earnings Transcripts
Burning Rock Biotech Limited (BNR) Q2 2022 Earnings Call Transcript
BNR earnings call for the period ending June 30, 2022.
Burning Rock Biotech Limited (BNR) Q1 2022 Earnings Call Transcript
BNR earnings call for the period ending March 31, 2022.
Burning Rock Biotech Limited (BNR) Q4 2021 Earnings Call Transcript
BNR earnings call for the period ending December 31, 2021.
Burning Rock Biotech Limited (BNR) Q3 2021 Earnings Call Transcript
BNR earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.